Related Experiment Video
Updated: Mar 2, 2026

An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment
Published on: April 20, 2018
Atorvastatin reduces cardiac and adipose tissue inflammation in rats with metabolic syndrome
Yuichiro Yamada1, Shino Takeuchi2, Mamoru Yoneda1
1Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Insights
Atorvastatin reduced inflammation and fibrosis in a rat model of metabolic syndrome. These anti-inflammatory effects are linked to increased AMP-activated protein kinase (AMPK) and decreased nuclear factor-kappa B (NF-κB) activity.
Area of Science:
- Cardiovascular Pharmacology
- Metabolic Syndrome Research
- Inflammation Biology
Background:
- Statins inhibit cholesterol synthesis and prevent cardiovascular disease.
- Statins possess cholesterol-independent anti-inflammatory effects with unclear mechanisms.
- Metabolic syndrome (MetS) models are crucial for studying related pathologies.
Purpose of the Study:
- To investigate atorvastatin's effects on cardiac and adipose tissue inflammation in a rat model of MetS.
- To elucidate the molecular mechanisms behind atorvastatin's pleiotropic anti-inflammatory actions.
Main Methods:
- DS/obese rats, a MetS model, were treated with atorvastatin (6 or 20mg/kg/day).
- Cardiac and adipose tissue inflammation markers were assessed.
- Gene expression of peroxisome proliferator-activated receptor γ, adiponectin levels, AMP-activated protein kinase (AMPK), and nuclear factor-kappa B (NF-κB) activities were analyzed.
Main Results:
- Atorvastatin ameliorated cardiac fibrosis, diastolic dysfunction, oxidative stress, and inflammation.
- Both cardiac and adipose tissue inflammation were reduced by atorvastatin at both doses.
- Atorvastatin activated AMPK and inactivated NF-κB in the heart, while modulating these in adipose tissue.
Conclusions:
- Atorvastatin's anti-inflammatory effects on the heart and adipose tissue in this MetS model are partly due to increased AMPK and decreased NF-κB activity.
- These findings contribute to understanding the pleiotropic effects of statins beyond cholesterol reduction.
Background:
Statins are strong inhibitors of cholesterol biosynthesis and help to prevent cardiovascular disease. They also exert additional pleiotropic effects that include an anti-inflammatory action and are independent of cholesterol, but the molecular mechanisms underlying these additional effects have remained unclear. We have now examined the effects of atorvastatin on cardiac and adipose tissue inflammation in DahlS.Z-Leprfa/Leprfa (DS/obese) rats, which we previously established as a model of metabolic syndrome (MetS).
Methods And Results:
DS/obese rats were treated with atorvastatin (6 or 20mgkg-1day-1) from 9 to 13weeks of age. Atorvastatin ameliorated cardiac fibrosis, diastolic dysfunction, oxidative stress, and inflammation as well as adipose tissue inflammation in these animals at both doses. The high dose of atorvastatin reduced adipocyte hypertrophy to a greater extent than did the low dose. Atorvastatin inhibited the up-regulation of peroxisome proliferator-activated receptor γ gene expression in adipose tissue as well as decreased the serum adiponectin concentration in DS/obese rats. It also activated AMP-activated protein kinase (AMPK) as well as inactivated nuclear factor-κB (NF-κB) in the heart of these animals. The down-regulation of AMPK and NF-κB activities in adipose tissue of DS/obese rats was attenuated and further enhanced, respectively, by atorvastatin treatment.
Conclusions:
The present results suggest that the anti-inflammatory effects of atorvastatin on the heart and adipose tissue are attributable at least partly to increased AMPK activity and decreased NF-κB activity in this rat model of MetS.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Considering cholesterol and...
Inflammation
